Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	-57.93	23.99	57.03
Graham Fair Price	42.66	13.77	9.65
PEG	-73.17	0.09	-0.34
Price/Book	-8.53	5.98	6.53
Price/Cash Flow	-53.49	21.55	46.32
Prices/Earnings	-54.09	9.24	20.12
Price/Sales	-54.09	3.72	8.11
Price/FCF	-53.49	21.55	46.32
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	126.26	0.41	-0.18
Operating Margin	-1.46	0.16	0.16
ROA	99.24	0.04	0.02
ROE	0.08	0.16	99.24
ROIC	0.04	0.08	102.43
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	-0.02	-0.04	45.90
Dividends QOQ	-0.02	0.01	-50.47
EBIT QOQ	-0.55	0.96	75.34
EPS QOQ	-0.59	1.02	71.14
FCF QOQ	0.02	0.97	4672.25
Revenue QOQ	-0.53	0.99	87.08
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	26.76	26.75	-0.06
Days Sales Outstanding (DSO)	24.82	19.20	-22.62
Inventory Turnover	3.36	3.36	0.06
Debt/Capitalization	0.62	0.60	-2.38
Quick Ratio	0.40	0.51	30.11
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	7.14	7.22	1.07
Cash	2.08	2.35	12.94
Capex	-0.19	-0.38	-99.62
Free Cash Flow	1.01	2.00	98.76
Revenue	5.76	11.59	101.36
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	0.76	0.76	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	9.99	4.42	-55.76
Naive Interpretation	Member

06 - Financial Health · Bad

Rating